Cardio Diagnostics Holdings, Inc. — Investor Relations & Filings
Filings indexed
274
across all filing types
Latest filing
2026-05-15
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
CDIO
Cardio Diagnostics Holdings, Inc. is a biotechnology company specializing in the development and commercialization of clinical tests for cardiovascular disease. The company leverages a proprietary platform that integrates artificial intelligence with epigenetics and genetics to enable early detection and prevention of heart disease. Its primary products are blood-based tests, including Epi+Gen CHD and PrecisionCHD™, which assess a patient's risk for coronary heart disease. These diagnostic tools analyze an individual's unique genetic and epigenetic markers to provide personalized insights, aiming to make cardiovascular care more precise and accessible for clinicians and patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| QUARTERLY REPORT | 2026-05-15 | English | |
| 8-K - CARDIO DIAGNOSTICS HOLDINGS, INC. (0001870144) (Filer) | 2026-02-19 | English | |
| PRIMARY DOCUMENT | 2026-01-06 | English | |
| PRIMARY DOCUMENT | 2026-01-06 | English | |
| PRIMARY DOCUMENT | 2026-01-06 | English | |
| PRIMARY DOCUMENT | 2026-01-06 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 46362674 | QUARTERLY REPORT | 2026-05-15 | English | ||
| 32900184 | 8-K - CARDIO DIAGNOSTICS HOLDINGS, INC. (0001870144) (Filer) | 2026-02-19 | English | ||
| 13489635 | PRIMARY DOCUMENT | 2026-01-06 | English | ||
| 13489636 | PRIMARY DOCUMENT | 2026-01-06 | English | ||
| 13489637 | PRIMARY DOCUMENT | 2026-01-06 | English | ||
| 13489638 | PRIMARY DOCUMENT | 2026-01-06 | English | ||
|
2025
9 filings
| |||||
| 13489639 | FORM 10-Q | 2025-11-12 | English | ||
| 13489640 | FORM 8-K | 2025-10-15 | English | ||
| 13489641 | PRIMARY DOCUMENT | 2025-10-03 | English | ||
| 13489642 | PRIMARY DOCUMENT | 2025-10-03 | English | ||
| 13489643 | PRIMARY DOCUMENT | 2025-10-03 | English | ||
| 13489644 | PRIMARY DOCUMENT | 2025-10-03 | English | ||
| 13489645 | PROSPECTUS | 2025-09-23 | English | ||
| 13489646 | Regulatory Filings 2025 | 2025-09-22 | English | ||
| 13489647 | POST-EFFECTIVE AMENDMENT NO. 1 | 2025-09-16 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Beijing Sun-Novo Pharmaceutical Research Co.,Ltd.
Integrated CRO providing full-spectrum R&D from drug discov…
|
688621 | CN | Professional, scientific and te… |
|
BenevolentAI
Applies artificial intelligence to accelerate drug discover…
|
BAI | LU | Professional, scientific and te… |
|
Berry Genomics Co.,Ltd
Provides clinical genomics and genetic testing for prenatal…
|
000710 | CN | Professional, scientific and te… |
|
BetterLife Pharma
Developing non-hallucinogenic neuroplastogens for severe ne…
|
BETR | CA | Professional, scientific and te… |
|
BGI Genomics Co., Ltd.
Provides integrated solutions for precision medicine via ge…
|
300676 | CN | Professional, scientific and te… |
|
bioAffinity Technologies, Inc.
Develops noninvasive diagnostics and targeted therapeutics …
|
BIAF | US | Professional, scientific and te… |
|
BioArctic
Biopharmaceutical firm developing antibody therapies for ne…
|
BIOA | SE | Professional, scientific and te… |
|
BIOCYTOGEN PHARMACEUTICALS (BEIJING) CO., LTD.
Develops antibody therapeutics using proprietary RenMice ge…
|
688796 | CN | Professional, scientific and te… |
|
BIO-GENE TECHNOLOGY LTD
Develops novel insecticides from natural chemistry to comba…
|
BGT | AU | Professional, scientific and te… |
|
BioInfra Co.,Ltd.
Develops multi-biomarker blood tests for early cancer scree…
|
199730 | KR | Professional, scientific and te… |
Cardio Diagnostics Holdings, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35336/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35336 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35336 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35336 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35336}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cardio Diagnostics Holdings, Inc. (id: 35336)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.